
In this episode, Jean-Laurent Casanova, MD, PhD, the winner of the 2026 Nemmers Prize, discusses his paradigm-shifting discoveries and what they reveal about immunity, genetic predisposition and why some people develop life-threatening infections while others do not.

In this episode, Nicole Woitowich, PhD, executive director of Northwestern University Clinical and Translational Sciences Institute (NUCATS), discusses her new study examining how well biomedical research is incorporating sex differences, and where science is still falling short.

In this episode, Peter Penzes, PhD, director of the Center for Autism and Neurodevelopment at Northwestern University Feinberg School of Medicine, discusses a recent discovery of a schizophrenia biomarker and how this research could one day offer earlier diagnosis, more precise treatment, and better outcomes for patients.

In this episode, Aimen Shaaban, MD, explains how the device works, explains how the collaboration took place and what it will take to bring this technology out of the lab and into clinical care.

In this episode, Jennie Kwon, DO, discusses the growing global threat of antimicrobial resistance and why this crisis could fundamentally disrupt modern medicine.

A new, rapid Hepatitis C test developed by Northwestern University scientists could change the future of Hepatitis C care by delivering faster diagnosis and treatments for a disease that is estimated to impact 50 million people around the world. In this episode, Claudia Hawkins, MD, explains this study and the impact this test could have…

Igor Koralnik, MD, chief of Neuro-Infectious Diseases and Global Neurology in the Department of Neurology at Feinberg has studied the long-term neurological effects of COVID-19 and developed tools to support patient recovery.

A novel functional MRI (fMRI) technique has been developed by Northwestern Medicine investigators to more accurately assess blood flow in the spinal cord. In this episode, Molly Bright, DPhil, explains how his noninvasive method could one day help clinicians detect early signs of neurological disease or injury, monitor recovery and guide treatment decisions for patients…

Lyme disease, the bacterial infection transmitted by ticks, is the most common vector-borne disease in the United States, with nearly half a million people diagnosed and treated each year, according to the CDC. Two pivotal studies on Lyme disease from the lab of Brandon Jutras, PhD, provide important insights into what may cause persistent Lyme…
The tiniest parts of the cell may provide new insights into challenging neurodegenerative diseases like amyotrophic lateral sclerosis (ALS). New research from Northwestern University has revealed a key mechanism underlying the development of motor neuron diseases, such as ALS, offering new insights into potential treatment options. This new finding published in the Journal of Neuroscience,…